American Healthcare REIT, Inc. $AHR Stake Trimmed by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH lessened its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 4.7% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 420,977 shares of the company’s stock after selling 20,729 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in American Healthcare REIT were worth $15,467,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Physician Wealth Advisors Inc. purchased a new position in shares of American Healthcare REIT in the second quarter worth approximately $34,000. Avalon Trust Co acquired a new position in American Healthcare REIT in the 1st quarter worth approximately $36,000. GAMMA Investing LLC boosted its stake in American Healthcare REIT by 22.1% in the 2nd quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock worth $63,000 after purchasing an additional 311 shares during the period. Meeder Asset Management Inc. purchased a new position in American Healthcare REIT during the 1st quarter worth approximately $97,000. Finally, Grove Bank & Trust acquired a new stake in American Healthcare REIT during the 2nd quarter valued at $130,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

American Healthcare REIT Stock Performance

Shares of NYSE AHR opened at $49.16 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.44 and a quick ratio of 0.44. American Healthcare REIT, Inc. has a one year low of $26.40 and a one year high of $50.51. The business’s 50-day moving average price is $43.81 and its two-hundred day moving average price is $39.73. The company has a market capitalization of $8.70 billion, a P/E ratio of 351.15, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 2.0%. American Healthcare REIT’s payout ratio is presently 714.29%.

Insider Buying and Selling

In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the business’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the sale, the executive vice president directly owned 59,100 shares of the company’s stock, valued at $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jeffrey T. Hanson sold 20,010 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $49.68, for a total transaction of $994,096.80. Following the transaction, the director owned 21,798 shares in the company, valued at approximately $1,082,924.64. This trade represents a 47.86% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 25,360 shares of company stock worth $1,229,398 in the last 90 days. 1.00% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently commented on AHR. Royal Bank Of Canada raised their target price on American Healthcare REIT from $45.00 to $54.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 12th. JMP Securities upped their price target on American Healthcare REIT from $45.00 to $50.00 and gave the company a “market outperform” rating in a research report on Friday, October 17th. UBS Group increased their price objective on American Healthcare REIT from $51.00 to $56.00 and gave the stock a “buy” rating in a research note on Monday. Zacks Research raised American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 17th. Finally, Citigroup reiterated an “outperform” rating on shares of American Healthcare REIT in a report on Friday, October 17th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, American Healthcare REIT has an average rating of “Buy” and an average price target of $50.60.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.